Literature DB >> 18761564

Shortening of median door-to-balloon time in primary percutaneous coronary intervention in Singapore by simple and inexpensive operational measures: clinical practice improvement program.

Chi-Hang Lee1, Shirley B S Ooi, Edgar L Tay, Adrian F Low, Swee-Guan Teo, Cindy Lau, Bee-Choo Tai, Irene Lim, Susan Lam, Ing-Haan Lim, Ping Chai, Huay-Cheem Tan.   

Abstract

BACKGROUND: Primary percutaneous coronary intervention is the standard reperfusion strategy for ST-segment elevation myocardial infarction in our center. We aimed to shorten the median door-to-balloon time from over 100 minutes to 90 minutes or less.
METHODS: We have been using three strategies since March 2007 to shorten the door-to-balloon time: (1) the intervention team is now activated by emergency department physicians (where previously it had been activated by coronary care unit); (2) all members of the intervention team have converted from using pagers to using cell phones; and (3) as soon as the intervention team is activated, patients are transferred immediately to the cardiac catheterization laboratory (where previously they had waited in the emergency department for the intervention team to arrive). An in-house physician and a nurse would stay with the patients before arrival of the intervention team.
RESULTS: During 12 months, 285 nontransfer patients (analyzed, n = 270) underwent primary PCI. The shortest monthly median door-to-balloon time was 59 minutes; the longest monthly median door-to-balloon time was 111 minutes. The overall median door-to-balloon time for the entire 12 months was 72 minutes. On a per-month basis, the median door-to-balloon time was 90 minutes or less in 10 of 12 months. On a per-patient basis, the median door-to-balloon time was 90 minutes or less in 182 patients (67.4%). There was 1 case (0.4%) of inappropriate activation by the emergency department. While waiting for the intervention team to convene, 1 patient (0.4%) deteriorated and had to be resuscitated in the cardiac catheterization laboratory.
CONCLUSIONS: Improved health care delivery can be achieved by changing simple and inexpensive operational processes.

Entities:  

Mesh:

Year:  2008        PMID: 18761564     DOI: 10.1111/j.1540-8183.2008.00389.x

Source DB:  PubMed          Journal:  J Interv Cardiol        ISSN: 0896-4327            Impact factor:   2.279


  4 in total

1.  Implementation of temporal lobe contouring protocol in head and neck cancer radiotherapy planning: A quality improvement project.

Authors:  Francis Ho; Jeremy Tey; David Chia; Yu Yang Soon; Chek Wee Tan; Sarahatul Bahiah; Timothy Cheo; Ivan Weng Keong Tham
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.817

2.  Relationship of Neighborhood Deprivation and Outcomes of a Comprehensive ST-Segment-Elevation Myocardial Infarction Protocol.

Authors:  Chetan P Huded; Jarrod E Dalton; Anirudh Kumar; Nikolas I Krieger; Nicholas Kassis; Michael Phelan; Kathleen Kravitz; Grant W Reed; Amar Krishnaswamy; Samir R Kapadia; Umesh Khot
Journal:  J Am Heart Assoc       Date:  2021-11-15       Impact factor: 5.501

3.  A hospital-wide system to ensure rapid treatment time across the entire spectrum of emergency percutaneous intervention.

Authors:  Umesh N Khot; Michele L Johnson-Wood; Robert VanLeeuwen; Curtis Ramsey; Monica B Khot
Journal:  Catheter Cardiovasc Interv       Date:  2015-12-23       Impact factor: 2.692

4.  Prehospital Activation of Hospital Resources (PreAct) ST-Segment-Elevation Myocardial Infarction (STEMI): A Standardized Approach to Prehospital Activation and Direct to the Catheterization Laboratory for STEMI Recommendations From the American Heart Association's Mission: Lifeline Program.

Authors:  Michael C Kontos; Michael R Gunderson; Jessica K Zegre-Hemsey; David C Lange; William J French; Timothy D Henry; James J McCarthy; Claire Corbett; Alice K Jacobs; James G Jollis; Steven V Manoukian; Robert E Suter; David T Travis; J Lee Garvey
Journal:  J Am Heart Assoc       Date:  2020-01-20       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.